Fingerprint
Dive into the research topics of 'Temozolomide for corticotroph pituitary adenomas refractory to standard therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Temozolomide for corticotroph pituitary adenomas refractory to standard therapy
Troy H. Dillard, S. Humayun Gultekin, Johnny B. Delashaw, Chris G. Yedinak, Edward A. Neuwelt, Maria Fleseriu
Research output: Contribution to journal › Article › peer-review
56
Scopus
citations